Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Clover Health sells Medicare Advantage health insurance plans and uses its own software to help doctors catch and treat illnesses earlier.
Clover Health is a health insurance company that mostly sells Medicare Advantage plans — the version of Medicare where the government pays a private insurer a fixed amount per member, and the insurer covers that person's care. Its customers are mainly older adults and people with lower incomes who qualify for both Medicare and Medicaid. The company's bet is that by using its software to flag health problems early and keep members out of the hospital, it can spend less on care than the government pays it and keep the difference.
That software, called Clover Assistant, is the piece that makes Clover different from a typical insurer. It sits on a doctor's screen and nudges them toward tests and treatments the data suggests a patient may need — a nudge toward catching diabetes or kidney disease before it gets expensive. Clover also runs a separate business through its subsidiary Counterpart, which helps other doctors' groups care for their own Medicare patients. Most of the money still comes from insurance premiums, though; the software side is small. The honest version of the story is that Clover has struggled. It went public in early 2021 by merging with a blank-check company, and the stock has fallen a long way from its early highs. For years it lost money, and regulators once flagged its risk-adjustment practices — the way insurers document how sick members are, which affects how much the government pays. Clover has since improved its finances, cutting losses and posting its first profitable quarter in 2024, and it has been growing membership. It competes against far bigger insurers like UnitedHealth Group, Humana, and CVS Health, which owns Aetna. Clover's edge is that it's small and focused on one niche: Medicare members in poorer, sicker communities that bigger insurers often find hard to manage profitably.
In 2014, Vivek Garipalli and Andrew Toy started Clover Health with a bet that software could help doctors make better decisions for older patients on Medicare. The company sold Medicare Advantage plans, a kind of private insurance for seniors, but the real product underneath was Clover Assistant, a tool meant to feed doctors useful information at the moment they treat a patient.
The software went live in 2018, designed to give doctors real-time clinical guidance and get paid quickly for visits made through the platform. The fast payment was the lure: if using the tool made a doctor's life easier and their wallet fuller, they would keep using it, and Clover's data would get richer.
Clover announced in late 2020 that it would go public by merging with a blank-check company backed by Chamath Palihapitiya, valuing the business at $3.7 billion. It started trading in January 2021 and ended its first day worth about $7 billion, a stunning debut for a company still losing money.
A month after the debut, short seller Hindenburg Research published a report claiming Clover had hidden a Department of Justice investigation and questioning whether Clover Assistant was as valuable as advertised. The stock fell, the company disclosed an SEC investigation, and its bold promise of $3 billion in revenue by 2023 landed nowhere close.
That spring, a wave of Reddit traders turned Clover into a short-squeeze target, pushing the stock to a 52-week high in June with no company news behind it. The spike faded fast, and the shares sank back far below their opening-day value, leaving a lot of ordinary investors holding the bag.
At the end of 2022, Garipalli stepped out of the CEO seat and handed the job to Andrew Toy, a former Google Cloud and Apple AI executive who had been pushing the technology-first vision. Garipalli stayed on as executive chairperson, and Toy set out to prove the software could actually make the insurance business work.
By the second quarter of 2026, the turnaround showed up in the numbers: net income of $28 million, a swing from a loss a year earlier, with Medicare Advantage membership up 48% to about 157,000. Clover raised its full-year guidance and aimed at its first full year of GAAP profitability, crediting Clover Assistant reaching more doctors and members and better economics on each new group of members.
In mid-2026, Brady Priest stepped down as CEO of the home-care unit with no successor named, as Clover folded that unit into the broader operation. The move centralized leadership so technology, care delivery and resources could be aligned under one roof.
The company's basic economic problem is that it earns a fixed fee per member but pays for whatever care that member needs. If Clover's software works, it saves money on hospital visits and keeps the savings. If it doesn't, Clover eats the losses. That's why the whole company hinges on whether its technology actually keeps people healthier — a claim that's easy to make and hard to prove.
Saved answer · last researched 2 Nov 2026